Ikarian Capital, LLC Hookipa Pharma Inc. Call Options Transaction History
Ikarian Capital, LLC
- $754 Million
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HOOK
# of Institutions
50Shares Held
32.5MCall Options Held
105KPut Options Held
43.6K-
Baker Bros. Advisors LP New York, NY8.13MShares$4.8 Million0.07% of portfolio
-
Artal Group S.A. Luxembourg, N45.67MShares$3.34 Million0.22% of portfolio
-
Knoll Capital Management, LLC Miami, FL5.52MShares$3.26 Million2.45% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.6MShares$2.71 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.12MShares$1.25 Million0.0% of portfolio
About HOOKIPA Pharma Inc.
- Ticker HOOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,654,500
- Market Cap $30.5M
- Description
- HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...